Effect of pupillary dilatation on optical biometry parameters and intraocular lens power calculation Authors: Uma Shroff, Uday Gajiwala, Kavin Shroff Published: 2026 Dear Editor, Accurate ocular biometry is fundamental to achieving optimal refractive outcomes following cataract surgery. Optical biometry devices based on optical coherence interferometry provide highly reproducible measurements of axial length (AL), anterior chamber depth (ACD), and keratometry, which form the basis of modern intraocular lens (IOL) power calculation formulas.[12] However, whether biometric measurements should be routinely performed in the dilated or undilated state remains a practical question in everyday cataract practice. We conducted a retrospective analysis to evaluate the effect of pupillary dilatation on optical biometry parameters and IOL power calculation in routine clinical settings. The study included 156 eyes of 156 patients who underwent uneventful phacoemulsification between March 2022 and December 2024 and had complete optical biometry data available in both undilated and dilated states. All measurements were obtained using the IOLMaster-500™. Pupillary dilatation was performed using topical tropicamide (0.8%) combined with phenylephrine (5%), as per the institutional protocol. Biometric parameters assessed included AL, ACD, flattest keratometry (K1), steepest keratometry (K2), and calculated IOL power using the SRK/T and Barrett Toric formulas. Eyes with axial lengths <20 mm or >24 mm and those with ocular comorbidities were excluded to minimize confounding. Statistical analysis included paired t-tests for comparison of pre- and post-dilatation biometric parameters, Pearson correlation to assess agreement between measurements, and Chi-square testing to evaluate the association between pupil status and postoperative residual refractive error, with P < 0.05 considered statistically significant (STATA 14.0). After dilatation, AL increased from 22.55 ± 3.23 mm to 23.00 ± 0.72 mm (P = 0.012) and ACD increased from 3.04 ± 0.55 mm to 3.20 ± 0.33 mm (P < 0.001). Keratometry did not change significantly (K1: 43.33 ± 6.29 D vs 44.13 ± 1.78 D, P = 0.144; K2: 44.56 ± 6.50 D vs 45.25 ± 2.56 D, P = 0.153). Despite these biometric changes, the mean calculated IOL power did not differ significantly before and after dilatation using either SRK/T or Barrett Toric formulas (SRK/T: 21.57 ± 1.48 D vs 21.56 ± 1.48 D, P = 0.869; Barrett Toric: 21.12 ± 1.45 D vs 21.19 ± 1.53 D, P = 0.089) [Tables 1 and 2]. These findings are consistent with earlier reports demonstrating that pharmacologic mydriasis can influence anterior segment parameters without necessarily translating into clinically meaningful changes in IOL power at a population level.[3456] Table 1Comparison of biometric parameters before and after pupil dilationMeasurementUndilated (Mean±SD)Dilated (Mean±SD)Mean Difference (Dilated - Undilated)Standard Deviation (SD) P Flattest Keratometry (K1) (D)43.33±6.2944.13±1.780.0470.400.144Steepest Keratometry (K2) (D)44.56±6.545.25±2.560.1971.700.153Anterior Chamber Depth (ACD) (mm)3.04±0.553.20±0.33-0.0980.19<0.001Axial Length (AL) (mm)22.55±3.2323.00±0.72-0.0270.130.012IOL Power (SRK/T) (D)21.57±1.4821.56±1.48-0.0060.490.869IOL Power (Barrett Toric) (D)21.12±1.4521.19±1.53-0.070.540.089SD: Standard Deviation. P<0.05 was considered statistically significant. AL: Axial Length; ACD: Anterior Chamber Depth; K1: Flattest Keratometry; K2: Steepest Keratometry. IOL: Intraocular Lens; SRK/T and Barrett Toric are IOL power calculation formulas Comparison of biometric parameters before and after pupil dilation SD: Standard Deviation. P<0.05 was considered statistically significant. AL: Axial Length; ACD: Anterior Chamber Depth; K1: Flattest Keratometry; K2: Steepest Keratometry. IOL: Intraocular Lens; SRK/T and Barrett Toric are IOL power calculation formulas Table 2Comparison of Residual Refractive Error at 1 Month Based on IOL Power Calculation MethodIOL Calculation MethodSample Size (n, %)Mean Residual Error (D)Zero Error [n (%), 95% CI]Myopic/Hyperopic Error [n (%), 95% CI]Undilated71 (46.2%)-0.1848 (67.6%), [56.2–77.6]23 (32.4%), [22.4–43.8]Dilated15 (9.7%)-0.0312 (80.0%), [55.6–94.0]3 (20.0%), [6.0–44.4]Over25 (16.2%)-0.0520 (80.0%), [61.6–91.9]5 (20.0%), [8.1–38.4]Both34 (22.1%)-0.0825 (73.5%), [57.2–86.0]9 (26.5%), [14.0–42.8]Average9 (5.8%)0.068 (88.9%), [58.6–98.8]1 (11.1%), [1.2–41.4]RE: Refractive Error; CI: Confidence Interval; n=Number of observations. Statistical significance assessed using Chi-square test. D: Diopters; CI: Confidence Interval; n: Number of eyes. Residual error defined at 1-month postoperative visit. Statistical comparison by Chi-square test (χ²=3.218, P=0.522) Comparison of Residual Refractive Error at 1 Month Based on IOL Power Calculation Method RE: Refractive Error; CI: Confidence Interval; n=Number of observations. Statistical significance assessed using Chi-square test. D: Diopters; CI: Confidence Interval; n: Number of eyes. Residual error defined at 1-month postoperative visit. Statistical comparison by Chi-square test (χ²=3.218, P=0.522) An important observation in our study was that although the mean IOL power remained unchanged, nearly 50% of individual eyes demonstrated some degree of variability in calculated IOL power following dilatation, with changes occurring in both myopic and hyperopic directions. Strong correlations between pre- and post-dilatation measurements suggest good internal consistency yet highlight that small biometric shifts may still influence individual IOL calculations. Similar inter-individual variability has been reported in previous studies evaluating the effect of pupil dilation on biometry and refractive prediction.[67] Postoperative residual refractive error at 1 month did not show a significant association with pupil status at the time of biometry (χ² = 3.218, P = 0.522). This suggests that while dilation-related biometric changes may not affect refractive outcomes at a group level, they may still be relevant in selected cases—particularly in refractive cataract surgery, toric IOL planning, or premium IOL implantation, where even small inaccuracies can influence visual satisfaction. Our findings support a pragmatic recommendation: Optical biometry should be performed under consistent pupillary conditions within a given clinical workflow. Standardization of measurement conditions may help reduce variability and improve reproducibility, especially with modern formulas that rely on accurate estimation of lens position and anterior segment parameters.[25] The retrospective design, limited formulae assessment, exclusion of eyes with extreme axial lengths, and lack of formal intra- and inter-operator repeatability analysis are acknowledged limitations. Prospective studies incorporating newer-generation formulas and including short and long eyes are needed to further clarify the clinical relevance of dilation-related biometric changes. Conflicts of interest There are no conflicts of interest.